A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.
Cuzick, J
A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults. [electronic resource] - British journal of cancer May 1987 - 523-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0007-0920
10.1038/bjc.1987.107 doi
Aged
Clinical Trials as Topic
Cyclophosphamide--adverse effects
Female
Humans
Leukemia, Myeloid, Acute--chemically induced
Male
Melphalan--adverse effects
Middle Aged
Models, Biological
Multiple Myeloma--drug therapy
Myelodysplastic Syndromes--chemically induced
Random Allocation
Risk
Time Factors
A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults. [electronic resource] - British journal of cancer May 1987 - 523-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0007-0920
10.1038/bjc.1987.107 doi
Aged
Clinical Trials as Topic
Cyclophosphamide--adverse effects
Female
Humans
Leukemia, Myeloid, Acute--chemically induced
Male
Melphalan--adverse effects
Middle Aged
Models, Biological
Multiple Myeloma--drug therapy
Myelodysplastic Syndromes--chemically induced
Random Allocation
Risk
Time Factors